Retirement Planning Group (New York)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,995
Closed -$242K 90
2025
Q2
$242K Buy
9,995
+68
+0.7% +$1.59K 0.21% 67
2025
Q1
$252K Buy
9,927
+194
+2% +$5.08K 0.26% 63
2024
Q4
$258K Buy
+9,733
New +$264K 0.28% 56

Other funds holding PFE

Retirement Planning Group (New York)'s PFE Position: Q3 2025 in Review

Retirement Planning Group (New York) sold out of Pfizer (PFE) in Q3 2025, closing a stake of 9,995 shares — an estimated $242K sold.

Retirement Planning Group (New York) first reported a position in PFE in Q4 2024 and held it in 3 quarters. The position peaked at $258K in Q4 2024. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Retirement Planning Group (New York) reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Retirement Planning Group (New York) sold 9,995 Pfizer shares in Q3 2025, an estimated $242K.
  • Retirement Planning Group (New York) first reported a position in Pfizer in Q4 2024 and held it in 3 quarters.
  • Retirement Planning Group (New York)'s Pfizer position peaked at $258K in Q4 2024.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Retirement Planning Group (New York)'s 13F filing for Q3 2025, filed 28 Oct 2025.